Skip to main navigation Skip to main content
The University of Southampton

Clinical Trials Unit gets funding boost

Published: 11 April 2013

The University of Southampton’s Clinical Trials Unit (UoSCTU) has received funding for a further five years to allow it to continue to facilitate and manage clinical trials for ground-breaking cancer treatments.

The £2.2million grant from Cancer Research UK Clinical Trials Awards and Advisory Committee will come into effect in October 2013.

UoSCTU Director Professor Diana Eccles says the funding will enable the team to improve outcomes for patients by delivering high-quality, robust clinical trials.

The 40-man UoSCTU arrange trials of lymphoma and haematological malignancy, gastrointestinal malignancy and urological cancers (testis, prostate), with immunotherapy, surgical trials and translational medicine as cross cutting themes.

Professor Eccles adds: “We work closely with academic clinicians from concept through design and funding application, then all the way to presentation of the final results. We support investigators to ensure their trials are run within the legislative and regulatory frameworks. The trials we help facilitate shape the future treatments given for a wide range of aggressive cancers. We are delighted to receive the grant, which is testament to the hard work of everyone in the Unit and to the organisations that have supported us.”

Cancer Research UK provides core funding for seven Clinical Trials Units across the UK including the UoSCTU.

The UoSCTU is based at Southampton General Hospital.

Privacy Settings